Straits Times Index
3,272.72 +47.55 (+1.47%) S&P 500
5,073.99 +63.39 (+1.27%) Dow
38,510.18 +270.20 (+0.71%) Nasdaq
15,723.21 +271.90 (+1.76%) Bitcoin USD
66,732.05 +185.16 (+0.28%) CMC Crypto 200
1,437.78 +23.02 (+1.63%)
Psychemedics Corporation (PMD)
| Previous close | 2.6100 |
| Open | 2.7495 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 2.5863 - 2.7495 |
| 52-week range | 2.0600 - 5.5900 |
| Volume | |
| Avg. volume | 9,290 |
| Market cap | 15.015M |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.7200 |
| Earnings date | 07 May 2024 - 13 May 2024 |
| Forward dividend & yield | 0.28 (10.55%) |
| Ex-dividend date | 24 May 2023 |
| 1y target est | N/A |
GlobeNewswirePsychemedics Corporation Reports 2023 Financial Results
DALLAS, March 28, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, announced today financial results for the year ended December 31, 2023. “2023 proved to be another challenging year due to the negative impact of major economic forces. The labor shortage continues and remains unprecedented in its severity and duration, having an adverse impact on our clients. Despite these challenges, my confidence in our potential
- GlobeNewswire
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
Dallas, TX, March 21, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in drug testing using hair analysis, is proud to announce its recognition as one of the Top 10 Employee Health Testing Services Providers for 2024 by ManageHR. This prestigious accolade highlights Psychemedics’ commitment to excellence and innovation in the field of employee health testing. ManageHR’s annual list recognizes companies that excel in providing cutting-edge solutions and services f
- GlobeNewswire
Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
ACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair testing for drugs of abuse, proudly announces the relocation of its corporate headquarters from Acton, Massachusetts, to Dallas, Texas, while reaffirming its unwavering dedication to delivering exceptional service and maintaining the highest standards in hair drug testing. The move to Dallas underscores Psychemedics’ commitment to expanding operations, fostering innovation, and better serving its di
